Phathom spikes as Cantor Fitzgerald bullish on IP claims
Phathom Pharmaceuticals (PHAT) stock rises as Cantor Fitzgerald issues an Overweight rating, rejecting its IP-rights related ...
Cantor Fitzgerald maintains $118 target on Ultragenyx stock
Cantor Fitzgerald reaffirmed its Overweight rating and $118.00 price target for Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company specializing in rare diseases. Currently ...
Phathom Pharmaceuticals initiated at Cantor Fitzgerald on ‘significant’ upside
Cantor Fitzgerald initiated coverage of Phathom Pharmaceuticals (PHAT) with an Overweight rating and $23 price target The firm cited ...
Seabridge Gold Announces US$100 Million in Financings Includes US$20 million from Strategic Investor
Seabridge Gold Inc. (TSX: SEA) (NYSE: SA) ("Seabridge" or the "Company") announced today it has entered into an agreement with RBC Capital Markets and Cantor Fitzgerald Canada Corporation (together ...
Cantor Fitzgerald Initiates Coverage on Domo, Inc. (DOMO) with Overweight Rating, $11 Target
We recently compiled a list of the 10 AI News Stories That Are Dominating Headlines. In this article, we are going to take a ...
Cantor Fitzgerald Remains a Buy on Kornit Digital (KRNT)
In a report released yesterday, Troy Jensen from Cantor Fitzgerald reiterated a Buy rating on Kornit Digital (KRNT – Research Report), with a ...